AP NEWS

2018 World’s Leading Generic Drug Companies: Mylan, Novartis, Pfizer, Sun Pharma & Teva - Capabilities, Goals and Strategies - ResearchAndMarkets.com

October 12, 2018

DUBLIN--(BUSINESS WIRE)--Oct 12, 2018--The “2018 World’s Leading Generic Drug Companies: Capabilities, Goals and Strategies” report has been added to ResearchAndMarkets.com’s offering.

This report is part of the Competitive Analysis Series to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation to the leading competitors.

The report analyzes the following companies:

Mylan Novartis Pfizer Sun Pharma Teva

The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs.

In the dynamic and fragmented Generic Drug industry, besieged by intense competition and rapid change of technological innovations, the ability to anticipate new product introductions and marketing strategies is particularly important...and can spell the difference between success and failure.

The report’s objectives include:

To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates. To complement organizations’ internal competitor information gathering efforts with strategic analysis, data interpretation and insight.

For more information about this report visit https://www.researchandmarkets.com/research/rdztb7/2018_worlds?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181012005328/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Generic Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/12/2018 11:34 AM/DISC: 10/12/2018 11:34 AM

http://www.businesswire.com/news/home/20181012005328/en

AP RADIO
Update hourly